Cargando…

Adult and Pediatric Intra-Institutional Trends of Ciprofloxacin Susceptibility in E. coli Positive Urinary Cultures

Antimicrobial drug resistance in treatment of urinary tract infection (UTI) continues to rise worldwide. To examine contributions of physician prescribing patterns to fluoroquinolone (ciprofloxacin, CP) resistance, we examined Escherichia coli (E. coli) resistance patterns in urinary cultures. Since...

Descripción completa

Detalles Bibliográficos
Autores principales:	Owumi, Winifred, Banaei, Niaz, Shortliffe, Linda D.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2014
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4790391/ https://www.ncbi.nlm.nih.gov/pubmed/27025742 http://dx.doi.org/10.3390/antibiotics3020163

Ejemplares similares

Antimicrobial Susceptibility of E. coli Isolates from Intra-Abdominal Infections in the Asia-Pacific Region: Trends in Ciprofloxacin, Ceftriaxone, Cefepime, and Piperacillin/Tazobactam Susceptibility
por: Tsai, Chia-Hung, et al.
Publicado: (2023)

747 Implementation of weight-based blood culture collection in pediatric hematology/oncology patients
por: Lefterova, Martina I., et al.
Publicado: (2014)

Susceptibility to ciprofloxacin of Escherichia coli strains isolated from patients with chronic kidney disease
por: Ionete, Oana Mariana, et al.
Publicado: (2014)

Evolutionary Instability of Collateral Susceptibility Networks in Ciprofloxacin-Resistant Clinical Escherichia coli Strains
por: Sørum, Vidar, et al.
Publicado: (2022)

Effect of subinhibitory exposure to quaternary ammonium compounds on the ciprofloxacin susceptibility of Escherichia coli strains in animal husbandry
por: Maertens, H., et al.
Publicado: (2020)

Efficacy of Ciprofloxacin for Treatment of Cholera Associated with Diminished Susceptibility to Ciprofloxacin to Vibrio cholerae O1
por: Khan, Wasif Ali, et al.
Publicado: (2015)

2067. Novel Methodology for Same-Day Antimicrobial Susceptibility Testing on VITEK(®)2 for Gram-Negative Rod Bacteremia
por: Hogan, Catherine, et al.
Publicado: (2018)

Molecular Epidemiology of Ciprofloxacin-Resistant Escherichia coli Isolated from Community-Acquired Urinary Tract Infections in Korea
por: Kim, Bongyoung, et al.
Publicado: (2020)

Serogroup A Neisseria meningitidis with Reduced Susceptibility to Ciprofloxacin
por: Strahilevitz, Jacob, et al.
Publicado: (2008)

Susceptibility pattern of uropathogens to ciprofloxacin at the Ghana police hospital
por: Afriyie, Daniel Kwame, et al.
Publicado: (2015)

Carriage of ESBL/AmpC-producing or ciprofloxacin non-susceptible Escherichia coli and Klebsiella spp. in healthy people in Norway
por: Ulstad, Charlotte R., et al.
Publicado: (2016)

Presence of qnr gene in Escherichia coli and Klebsiella pneumoniae resistant to ciprofloxacin isolated from pediatric patients in China
por: Wang, Aihua, et al.
Publicado: (2008)

Effect of Ciprofloxacin-Loaded Niosomes on Escherichia coli and Staphylococcus aureus Biofilm Formation
por: Maurizi, Linda, et al.
Publicado: (2022)

Update of incidence and antimicrobial susceptibility trends of Escherichia coli and Klebsiella pneumoniae isolates from Chinese intra-abdominal infection patients
por: Zhang, Hui, et al.
Publicado: (2017)

Foreign Travel and Decreased Ciprofloxacin Susceptibility in Salmonella enterica Infections
por: Al-Mashhadani, Manar, et al.
Publicado: (2011)

Ciprofloxacin susceptibility reduction of Salmonella strains isolated from outbreaks
por: Souza, Roberta B., et al.
Publicado: (2010)

Ciprofloxacin resistance in community- and hospital-acquired Escherichia coli urinary tract infections: a systematic review and meta-analysis of observational studies
por: Fasugba, Oyebola, et al.
Publicado: (2015)

Can Ciprofloxacin be Used for Precision Treatment of Gonorrhea in Public STD Clinics? Assessment of Ciprofloxacin Susceptibility and an Opportunity for Point-of-Care Testing
por: Melendez, Johan H., et al.
Publicado: (2019)

Cellular Response to Ciprofloxacin in Low-Level Quinolone-Resistant Escherichia coli
por: Machuca, Jesús, et al.
Publicado: (2017)

Trends in Antimicrobial Susceptibility of Escherichia coli Isolates in a Taiwanese Child Cohort with Urinary Tract Infections between 2004 and 2018
por: Chen, Hung-En, et al.
Publicado: (2020)

Decreased susceptibility to ciprofloxacin in Salmonella enterica serotype typhi, United Kingdom.
por: Threlfall, E J, et al.
Publicado: (2001)

Shigella flexneri with Ciprofloxacin Resistance and Reduced Azithromycin Susceptibility, Canada, 2015
por: Gaudreau, Christiane, et al.
Publicado: (2016)

Disposition kinetics and urinary excretion of ciprofloxacin in goats following single intravenous administration
por: Raina, R., et al.
Publicado: (2008)

Levofloxacin Versus Ciprofloxacin in the Treatment of Urinary Tract Infections: Evidence-Based Analysis
por: Cao, Dehong, et al.
Publicado: (2021)

Clinical Impact of Revised Ciprofloxacin Breakpoint in Patients with Urinary Tract Infections by Enterobacteriaceae
por: Park, Ga Eun, et al.
Publicado: (2021)

Clinical and laboratory standards institute versus European committee for antimicrobial susceptibility testing guidelines for interpretation of carbapenem antimicrobial susceptibility results for Escherichia coli in urinary tract infection (UTI)
por: Sahu, Chinmoy, et al.
Publicado: (2018)

Traveler's encounter with nymphs in a hotel bed
por: Sandlund, Johanna, et al.
Publicado: (2014)

Ciprofloxacin Causes Persister Formation by Inducing the TisB toxin in Escherichia coli
por: Dörr, Tobias, et al.
Publicado: (2010)

Ciprofloxacin-resistant Escherichia coli in Central Greece: mechanisms of resistance and molecular identification
por: Mavroidi, Angeliki, et al.
Publicado: (2012)

Increased expression of Qnr is sufficient to confer clinical resistance to ciprofloxacin in Escherichia coli
por: Garoff, Linnéa, et al.
Publicado: (2018)

Mutation Supply and Relative Fitness Shape the Genotypes of Ciprofloxacin-Resistant Escherichia coli
por: Huseby, Douglas L., et al.
Publicado: (2017)

Understanding and predicting ciprofloxacin minimum inhibitory concentration in Escherichia coli with machine learning
por: Pataki, Bálint Ármin, et al.
Publicado: (2020)

Cuminaldehyde potentiates the antimicrobial actions of ciprofloxacin against Staphylococcus aureus and Escherichia coli
por: Monteiro-Neto, Valério, et al.
Publicado: (2020)

Evolution of antimicrobial resistance in E. coli biofilm treated with high doses of ciprofloxacin
por: Nesse, Live L., et al.
Publicado: (2023)

Vibrio cholerae O1 Variant with Reduced Susceptibility to Ciprofloxacin, Western Africa
por: Quilici, Marie-Laure, et al.
Publicado: (2010)

Serotyping and Antimicrobial Susceptibility Pattern of Escherichia coli Isolates from Urinary Tract Infections in Pediatric Population in a Tertiary Care Hospital
por: Sharma, Shweta, et al.
Publicado: (2016)

Choosing the correct empirical antibiotic for urinary tract infection in pediatric: Surveillance of antimicrobial susceptibility pattern of Escherichia coli by E-Test method
por: Sedighi, Iraj, et al.
Publicado: (2014)

Antimicrobial Susceptibilities of Urinary Extended-spectrum β-lactamase Escherichia coli to Fosfomycin
por: Saeed, Nermin Kamal, et al.
Publicado: (2021)

Bacteriological profile of urinary tract infections and antibiotic susceptibility of Escherichia coli in Algeria
por: Ait-Mimoune, Nouara, et al.
Publicado: (2022)

Piperacillin/tazobactam versus cefepime or carbapenems for cefoxitin-non-susceptible Enterobacter cloacae, Klebsiella aerogenes, Citrobacter freundii, Serratia marcescens and Morganella morganii bacteraemia in immunocompromised patients
por: Lu, Brian, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_ja9j849qll99g7pkkrurp3scq8